Esperion Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Company Overview - Esperion is focused on discovering, developing, and commercializing innovative medicines aimed at improving outcomes for patients with cardiovascular and cardiometabolic diseases [4] - The company addresses the unmet health needs of millions suffering from high cholesterol, emphasizing the importance of reducing LDL-cholesterol levels effectively [4] Equity Incentive Plan - On September 23, 2024, Esperion granted 3,500 restricted stock units (RSUs) to a new employee under its 2017 Inducement Equity Incentive Plan [1] - The 2017 Inducement Equity Incentive Plan is designed for granting equity awards to individuals who are new hires or returning after a bona fide period of non-employment, as an inducement for joining the company [2] RSU Vesting Schedule - Each RSU will vest 25% on the one-year anniversary of the vesting commencement date, with the remaining 75% vesting in twelve equal quarterly installments thereafter, contingent on the employee's continued employment [3]